Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects / Mohaddeseh Sajjadi, Mahmoud Nasrollahzadeh, Babak Jaleh, Ghazaleh Jamalipour Soufi, Siavash Iravani
Abstract Carbon-based nanomaterials are becoming attractive materials due to their unique structural dimensions and promising mechanical, electrical, thermal, optical and chemical characteristics. Carbon nanotubes, graphene, graphene oxide, carbon and graphene quantum dots have numerous applications in diverse areas, including biosensing, drug/gene delivery, tissue engineering, imaging, regenerative medicine, diagnosis, and cancer therapy. Cancer remains one of the major health problems all over the world, and several therapeutic approaches are focussed on designing targeted anticancer drug delivery nanosystems by applying benign and less hazardous resources with high biocompatibility, ease of functionalization, remarkable targeted therapy issues, and low adverse effects. This review highlights the recent development on these carbon based-nanomaterials in the field of targeted cancer therapy and discusses their possible and promising diagnostic and therapeutic applications for the treatment of cancers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Journal of drug targeting - 29(2021), 7, Seite 716-741 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sajjadi, Mohaddeseh [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Themen: |
Cancer nanotherapy |
|---|
| Umfang: |
1 Online-Ressource (26 p) |
|---|
| doi: |
10.1080/1061186X.2021.1886301 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL011113421 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011113421 | ||
| 003 | DE-627 | ||
| 005 | 20230713210745.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/1061186X.2021.1886301 |2 doi | |
| 035 | |a (DE-627)KFL011113421 | ||
| 035 | |a (KFL)prod_LgpH_10.1080/1061186X.2021.1886301 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Sajjadi, Mohaddeseh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects |c Mohaddeseh Sajjadi, Mahmoud Nasrollahzadeh, Babak Jaleh, Ghazaleh Jamalipour Soufi, Siavash Iravani |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (26 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Carbon-based nanomaterials are becoming attractive materials due to their unique structural dimensions and promising mechanical, electrical, thermal, optical and chemical characteristics. Carbon nanotubes, graphene, graphene oxide, carbon and graphene quantum dots have numerous applications in diverse areas, including biosensing, drug/gene delivery, tissue engineering, imaging, regenerative medicine, diagnosis, and cancer therapy. Cancer remains one of the major health problems all over the world, and several therapeutic approaches are focussed on designing targeted anticancer drug delivery nanosystems by applying benign and less hazardous resources with high biocompatibility, ease of functionalization, remarkable targeted therapy issues, and low adverse effects. This review highlights the recent development on these carbon based-nanomaterials in the field of targeted cancer therapy and discusses their possible and promising diagnostic and therapeutic applications for the treatment of cancers | ||
| 653 | |a Targeted drug delivery | ||
| 653 | |a cancer nanotherapy | ||
| 653 | |a nanocarriers | ||
| 653 | |a carbon nanotubes | ||
| 653 | |a graphene | ||
| 653 | |a graphene oxide | ||
| 653 | |a carbon quantum dots | ||
| 653 | |a graphene quantum dots | ||
| 700 | 1 | |a Nasrollahzadeh, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Jaleh, Babak |e verfasserin |4 aut | |
| 700 | 1 | |a Soufi, Ghazaleh Jamalipour |e verfasserin |4 aut | |
| 700 | 1 | |a Iravani, Siavash |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of drug targeting |d Abingdon : Taylor & Francis Group, 1993 |g 29(2021), 7, Seite 716-741 |h Online-Ressource |w (DE-627)KFL000006076 |w (DE-600)2041932-6 |w (DE-576)273880632 |x 1029-2330 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2021 |g number:7 |g pages:716-741 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/1061186X.2021.1886301 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TFE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_LgpH_02 | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2021 |e 7 |h 716-741 | ||